Neodocs

Currently, India has only 10,000 pathology labs for testing, serving a population of 1.3 billion people. However, most of these labs are concentrated in urban areas, making it challenging for the rural population to access them. Additionally, not all of these labs are NABL certified, raising concerns about the quality of machines used in these facilities. The high prices of these tests make it financially infeasible for many people to undergo multiple tests a year. Also there is a risk of sample contamination as well. As a result, many diseases go undiagnosed, preventing timely intervention and prevention.
To address these issues, we provide instant point-of-care testing that delivers results instantly without the usual 2-3 days wait.

- Companies Like healthy.io, vessel health, vivoo, testcard etc are a few companies globally.

We are able to capture 15 parameters which is higher than other products in the market, we also provide instant blood tests while the other products are only focused on urine tests, also we are the only product available in the SEA market.

Currently our GTM strategy is to go B2B where we are partnering with healthcare companies, Insurtech Companies, Pharma companies, Doctors, Hospitals, Clinics and Governments as well since our tests can be used by them for screening larger masses and then track progress of treatment with real world labelled data being generated.

Addressable market size in USD: 40 bil (Source)

---

Our Customers are Doctors, hospitals, clinics, Healthcare companies, insurtech companies, pharma companies, Governments. We are conducting successful pilots with many companies and building strong case studies. Using these case studies as refernce we are partnering attracting more customers.

Current in next 2 years we are going to be expanding in
1) Products: Currently we have commercialized our instant urine test kits, soon we'll be launching our blood based test as well like Hba1c, Hb, Hiv, malaria, dengue, ferritin, vitamin D etc.